Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Paul A J Russo"'
Autor:
Domenico Prisco, Giacomo Emmi, Gerardo Di Scala, Filippo Fagni, Alessandra Bettiol, Elena Silvestri, Giuseppe Lopalco, Paul A J Russo, Rosaria Talarico, Maria Letizia Urban
Publikováno v:
Annals of the rheumatic diseases. 79(8)
ObjectiveTo evaluate the effectiveness and safety of secukinumab in patients with a mucosal and articular Behçet’s phenotype resistant to conventional and biologic treatment.MethodsA multicentre retrospective study was performed on 15 patients wit
Autor:
Pravin Hissaria, Vidya Limaye, Tiffany Hughes, Susanna Proudman, Caroline Foreman, Noelene Davies, Paul A. J. Russo
Publikováno v:
Internal Medicine Journal. 47:112-115
In South Australia, between 2000 and 2014, 57 patients with idiopathic inflammatory myositis (IIM) were treated with intravenous immunoglobulin (IVIg). We reviewed disease characteristics to determine predictors of response to therapy and IVIg dosing
Autor:
Adrian Y.S. Lee, Tom P. Gordon, Paul A. J. Russo, Tim Chataway, Scott W. Graf, Alex D. Colella, Dimitra Beroukas, Jing J. Wang, Anthony J.F. Smith
Publikováno v:
Pathology. 52:S42-S43
Autor:
Axel Hauschild, S. Lischner, Stephanie Darabaneanu, Uwe Niederberger, Horia‐Alfred Darabaneanu, Paul A. J. Russo
Publikováno v:
Dermatologic Surgery. 34:1170-1177
Subcutaneous sweat gland suction curettage (SSGSC) is gaining acceptance as a therapy for axillary hyperhidrosis. Despite its acceptance, there remains a lack of prospective data describing the efficacy and long-term outcome of SSGSC.We examined the
Publikováno v:
International journal of rheumatic diseases. 17(5)
Aim A recent study identified increasing birth order to be a risk factor for the development of systemic sclerosis (SSc). This finding supports the theory that transplacental microchimerism may be a key pathological event in the initiation of SSc. We
Autor:
Michael Ahern, Malcolm D. Smith, Michael D. Wiese, Paul A. J. Russo, E. Michael Shanahan, Jeffrey A J Barbara
OBJECTIVE To study the pharmacokinetics and pharmacogenetics of leflunomide and document its efficacy and safety in the treatment of inflammatory arthritis in a patient with end-stage renal disease (ESRD) who was on peritoneal dialysis. CASE SUMMARY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::418fac1fc4a416e86ca7031819b3c7af
https://hdl.handle.net/1959.8/152660
https://hdl.handle.net/1959.8/152660
Autor:
Ernst Michael Shanahan, Malcolm D. Smith, Anthony Thomas, Michael Ahern, Paul A. J. Russo, Joseph B. Selvanayagam
Publikováno v:
International Journal of Rheumatic Diseases. 17:217-218
Autor:
Patrick H, Warnke, Hendrik, Terheyden, Yahya, Açil, Ingo N, Springer, Eugene, Sherry, Max, Reynolds, Paul A J, Russo, Joachim P, Bredee, Rainer, Podschun
Publikováno v:
Cancer. 100(4)
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 2:225-229.e1
We describe a patient with EDTA allergy, identified through investigation of reactions to local anaesthetic (LA) and radiocontrast medium (RCM). A 57-year-old man with a history of seasonal allergic rhinitis received a subcutaneous injection of appro
Publikováno v:
The World Allergy Organization Journal
peak .gp A .0.822 (0.155), gp B 0.326 ((0.106), 52 weeks gp A 0.453 (0.223) gp B 0.170 (0.059)]. sIgE responses showed a wide scatter with a rise from baseline of similar magnitude but occurring earlier in group A, followed by a progressive fall, [ba